7 December 2015 - Heart UK is calling on NICE to reverse its rejection of Amgen’s cholesterol-busting drug Repatha for use on the National Health Service in England and Wales, slamming the move for leaving high-risk patients in danger of suffering heart attack or stroke.

For more details, go to: http://www.pharmatimes.com/Article/15-12-07/Charity_calls_on_NICE_to_reverse_rejection_of_Amgen_s_PCSK9_inhibitor.aspx